Related Experiment Videos

Gene therapy trials: a patient pathway

Diana Hull1, Michelle Chester

  • 1Clinical Trials Unit, Cancer Research UK, Institute for Cancer Studies, Medical School, University of Birmingham. Diana.Hull@uhb.nhs.uk

Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|October 18, 2002
PubMed

Insights

Ongoing gene therapy clinical trials are exploring new cancer treatments for liver, head and neck, and prostate cancers. This research offers a potential alternative for patients unresponsive to traditional therapies.

Area of Science:

  • Oncology
  • Gene Therapy
  • Clinical Research

Background:

  • Conventional cancer treatments like chemotherapy and radiation are not always effective.
  • There is a need for novel therapeutic strategies for refractory cancers.
  • Gene therapy presents a promising avenue for targeted cancer intervention.

Purpose of the Study:

  • To describe ongoing gene therapy trials for specific cancer types.
  • To evaluate the potential of gene therapy as an alternative treatment modality.
  • To highlight advancements in cancer treatment research at University Hospital Birmingham NHS Trust.

Main Methods:

  • The study focuses on describing gene therapy trials.
  • Specific cancer types targeted include liver, head and neck, and prostate cancer.
  • The research involves patients who have not responded to conventional treatments.

Main Results:

  • Gene therapy trials are currently underway.
  • The research programme is exploring new treatment options.
  • The potential for gene therapy to benefit non-responsive patients is being investigated.

Conclusions:

  • Gene therapy trials show promise for specific cancer types.
  • This research may offer a viable alternative to conventional treatments.
  • Further investigation is warranted to establish gene therapy's efficacy in oncology.

Related Concept Videos